Diary - News
All news BioMeca and Synthelis sign a commercial agreement
 |
 |
As of February 12, 2018, Synthelis and BioMeca combine their know-how and thus capitalize on their respective technology in developing a joint offer, responding to the needs of their customers.
This joint offering is based on the production of difficult-to-express proteins and the validation of their proper folding by Atomic Force Microscopy (AFM). Thus, this offer combines the cutting-edge expertise of two recognized players in their respective domain: Synthelis, for its cell-free patented technology and BioMeca, for its expertise in the field of mechanical measurement on biological materials.
